Epitope mapping of the 2009 pandemic and the A/brisbane/59/2007 seasonal (H1N1) influenza virus haemagglutinins using mabs and escape mutants

Journal of General Virology

Volumn 95, Issue , 2014, Pages 2377-2389

  Retamal, Miguel ^a   Abed, Yacine ^a   Corbeil, Jacques ^a   Boivin, Guy ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; INFLUENZA VIRUS HEMAGGLUTININ; MONOCLONAL ANTIBODY; H1N1 VIRUS HEMAGGLUTININ; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGENIC VARIATION; ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; CROSS REACTION; ENZYME INHIBITION; EPITOPE MAPPING; ESCAPE MUTANT; HEK293 CELL LINE; HUMAN; HUMAN CELL; INFLUENZA A VIRUS (A/BRISBANE/59/2007(H1N1)); INFLUENZA VIRUS A H1N1; MOUSE; NONHUMAN; PANDEMIC INFLUENZA; SCREENING TEST; SEASONAL INFLUENZA; SEQUENCE ANALYSIS; VIRUS MUTANT; VIRUS MUTATION; VIRUS NEUTRALIZATION; ANIMAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; IMMUNOLOGY; INFLUENZA, HUMAN; MUTATION; PANDEMIC; PROTEIN CONFORMATION; SEASON; SEQUENCE HOMOLOGY; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; EPITOPE MAPPING; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNODOMINANT EPITOPES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MUTATION; PANDEMICS; PROTEIN CONFORMATION; SEASONS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84908302396     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.067819-0     Document Type: Article

References (45)

1. Abed, Y., Pizzorno, A., Hamelin, M. E., Leung, A., Joubert, P., Couture, C., Kobasa, D. & Boivin, G. (2011). The 2009 pandemic H1N1 D222G hemagglutinin mutation alters receptor specificity and increases virulence in mice but not in ferrets. J Infect Dis 204, 1008-1016.
2. Abed, Y., Pizzorno, A., Bouhy, X., Rhéaume, C. & Boivin, G. (2014). Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets. J Virol 88, 1652–1658.
3. Arora, D. J., Tremblay, P., Bourgault, R. & Boileau, S. (1985). Concentration and purification of influenza virus from allantoic fluid. Anal Biochem 144, 189–192.
4. Benjamin, E., Wang, W., McAuliffe, J. M., Palmer-Hill, F. J., Kallewaard, N. L., Chen, Z., Suzich, J. A., Blair, W. S., Jin, H. & Zhu, Q. (2014). A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head. J Virol 88, 6743–6750.
5. Brownlee, G. G. & Fodor, E. (2001). The predicted antigenicity of the haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian origin. Philos Trans R Soc Lond B Biol Sci 356, 1871–1876.
6. Caton, A. J., Brownlee, G. G., Yewdell, J. W. & Gerhard, W. (1982). The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31, 417–427.
7. Centers for Disease Control and Prevention (CDC) (2009). Outbreak of swine-origin influenza A (H1N1) virus infection -Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 58, 467-470.
8. Chen, J., Yan, B., Chen, Q., Yao, Y., Wang, H., Liu, Q., Zhang, S., Wang, H. & Chen, Z. (2014). Evaluation of neutralizing efficacy of monoclonal antibodies specific for 2009 pandemic H1N1 influenza A virus in vitro and in vivo. Arch Virol 159, 471–483.
9. Cutler, J., Schleihauf, E., Hatchette, T. F., Billard, B., Watson-Creed, G., Davidson, R., Li, Y., Bastien, N., Sarwal, S. & Nova Scotia Human Swine Influenza Investigation Team (2009). Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 181, 159–163.
10. Deem, M. W. & Pan, K. (2009). The epitope regions of H1-subtype influenza A, with application to vaccine efficacy. Protein Eng Des Sel 22, 543–546.
11. Domingo, E. & Holland, J. J. (1997). RNA virus mutations and fitness for survival. Annu Rev Microbiol 51, 151–178.
12. Fraser, C., Donnelly, C. A., Cauchemez, S., Hanage, W. P., Van Kerkhove, M. D., Hollingsworth, T. D., Griffin, J., Baggaley, R. F., Jenkins, H. E. & other authors (2009). Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324, 1557–1561.
13. Gerhard, W., Yewdell, J., Frankel, M. E. & Webster, R. (1981). Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. Nature 290, 713–717.
14. Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R. & other authors (2009). Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361, 1945–1952.
15. Hart, G. W. (1997). Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 66, 315–335.
16. Hatakeyama, S., Sakai-Tagawa, Y., Kiso, M., Goto, H., Kawakami, C., Mitamura, K., Sugaya, N., Suzuki, Y. & Kawaoka, Y. (2005). Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol 43, 4139–4146.
17. Hausmann, J., Kretzschmar, E., Garten, W. & Klenk, H. D. (1997). Biosynthesis, intracellular transport and enzymatic activity of an avian influenza A virus neuraminidase: role of unpaired cysteines and individual oligosaccharides. J Gen Virol 78, 3233–3245.
18. Holder, B. P., Simon, P., Liao, L. E., Abed, Y., Bouhy, X., Beauchemin, C. A. & Boivin, G. (2011). Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model. PLoS ONE 6, e14767.
19. Igarashi, M., Ito, K., Yoshida, R., Tomabechi, D., Kida, H. & Takada, A. (2010). Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin. PLoS ONE 5, e8553.
20. Köhler, G. & Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495–497.
21. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685.
22. Latterich, M. & Corbeil, J. (2008). Label-free detection of biomolecular interactions in real time with a nano-porous silicon-based detection method. Proteome Sci 6, 31.
23. Laver, W. G. & Webster, R. G. (1976). Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine. Virology 69, 511–522.
24. Lee, M. S. & Chen, J. S. (2004). Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 10, 1385–1390.
25. Lubeck, M. D. & Gerhard, W. (1981). Topological mapping antigenic sites on the influenza A/PR/8/34 virus hemagglutinin using monoclonal antibodies. Virology 113, 64–72.
26. Malarchuk, S. & Irvin, J. (2010). Antibody Screening and Characterization by Nanopore Optical Interferometry. San Diego, CA: Silicon Kinetics Inc. http://wwwsiliconkineticscom/pdf/SKI_Antibody_Screening_ and_Characterization_Poster_2010pdf
27. O’Donnell, C. D., Vogel, L., Wright, A., Das, S. R., Wrammert, J., Li, G. M., McCausland, M., Zheng, N. Y., Yewdell, J. W. & other authors (2012). Antibody pressure by a human monoclonal antibody targeting the 2009 pandemic H1N1 virus hemagglutinin drives the emergence of a virus with increased virulence in mice. MBio 3, e00120–e12.
28. Reid, A. H., Fanning, T. G., Janczewski, T. A. & Taubenberger, J. K. (2000). Characterization of the 1918 ‘‘Spanish’’ influenza virus neuraminidase gene. Proc Natl Acad Sci U S A 97, 6785–6790.
29. Robertson, J. S. & Engelhardt, O. G. (2010). Developing vaccines to combat pandemic influenza. Viruses 2, 532–546.
30. Robertson, J. S., Nicolson, C., Major, D., Robertson, E. W. & Wood, J. M. (1993). The role of amniotic passage in the egg-adaptation of human influenza virus is revealed by haemagglutinin sequence analyses. J Gen Virol 74, 2047–2051.
31. Robertson, J. S., Cook, P., Attwell, A. M. & Williams, S. P. (1995). Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture. Vaccine 13, 1583–1588.
32. Rudneva, I., Ignatieva, A., Timofeeva, T., Shilov, A., Kushch, A., Masalova, O., Klimova, R., Bovin, N., Mochalova, L. & Kaverin, N. (2012). Escape mutants of pandemic influenza A/H1N1 2009 virus: variations in antigenic specificity and receptor affinity of the hemagglutinin. Virus Res 166, 61–67.
33. Sanchez, A. B., Nguyen, T., Dema-Ala, R., Kummel, A. C., Kipps, T. J. & Messmer, B. T. (2010). A general process for the development of peptide-based immunoassays for monoclonal antibodies. Cancer Chemother Pharmacol 66, 919–925.
34. Skowronski, D. M., Hamelin, M. E., De Serres, G., Janjua, N. Z., Li, G., Sabaiduc, S., Bouhy, X., Couture, C., Leung, A. & other authors (2014). Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk. PLoS ONE 9, e86555.
35. Stahl-Hennig, C., Voss, G., Nick, S., Petry, H., Fuchs, D., Helmut, W., Coulibaly, C., Lüke, W. & Hunsmann, G. (1992). Immunization with tween-ether-treated SIV adsorbed onto aluminum hydroxide protects monkeys against experimental SIV infection. Virology 186, 588–596.
36. Steitz, J., Barlow, P. G., Hossain, J., Kim, E., Okada, K., Kenniston, T., Rea, S., Donis, R. O. & Gambotto, A. (2010). A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice. PLoS ONE 5, e10492.
37. Stephan, M., Kramer, C., Steinem, C. & Janshoff, A. (2014). Binding assay for low molecular weight analytes based on reflectometry of absorbing molecules in porous substrates. Analyst (Lond) 139, 1987-1992.
38. Thoennes, S., Li, Z. N., Lee, B. J., Langley, W. A., Skehel, J. J., Russell, R. J. & Steinhauer, D. A. (2008). Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion. Virology 370, 403–414.
39. Towbin, H., Staehelin, T. & Gordon, J. (1992). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology 24, 145–149.
40. Webster, R. G., Hinshaw, V. S. & Laver, W. G. (1982). Selection and analysis of antigenic variants of the neuraminidase of N2 influenza viruses with monoclonal antibodies. Virology 117, 93–104.
41. WHO (2002). Manual on animal influenza diagnosis and surveillance. http://whqlibdocwhoint/hq/2002/who_cds_csr_ncs_20025pdf
42. Wood, J. M. & Williams, M. S. (1998). History of inactivated vaccines. In Textbook of Influenza, 2nd edn, pp. 317–323. Edited by K. G. Nicholson, R. G. Webster & A. J. Hay. Oxford: Blackwell Science.
43. Wu, Y., Wu, Y., Tefsen, B., Shi, Y. & Gao, G. F. (2014). Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol 22, 183–191.
44. Yasugi, M., Kubota-Koketsu, R., Yamashita, A., Kawashita, N., Du, A., Misaki, R., Kuhara, M., Boonsathorn, N., Fujiyama, K. & other authors (2013). Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody. PLoS ONE 8, e77892.
45. Yiu, C. P. & Chen, Y. W. (2014). High-quality macromolecular graphics on mobile devices: a quick starter’s guide. Methods Mol Biol 1091, 343–352.